Navidea Biopharmaceuticals, Inc. (NAVB) Financial Statements (2024 and earlier)
Company Profile
Business Address |
4995 BRADENTON AVENUE DUBLIN, OH 43017 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 1,995,860 | 4,230,865 | 2,670,495 | 1,047,159 | 3,475,881 | 4,592,610 | |||
Cash and cash equivalents | 1,995,860 | 4,230,865 | 2,670,495 | 1,047,159 | 3,475,881 | 2,795,006 | |||
Short-term investments | 1,797,604 | ||||||||
Inventory, net of allowances, customer advances and progress billings | 427,344 | 151,155 | 169,798 | (748) | |||||
Inventory | 427,344 | 151,155 | 169,798 | (748) | |||||
Other undisclosed current assets | 780,740 | 1,001,265 | 3,688,035 | 1,868,624 | 2,119,875 | 9,240,543 | |||
Total current assets: | 3,203,944 | 5,383,285 | 6,528,328 | 2,915,783 | 5,595,756 | 13,832,405 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 20,300 | 128,215 | 250,095 | 281,688 | ✕ | ✕ | |||
Property, plant and equipment | 135,347 | 120,490 | 132,162 | 30,210 | 162,172 | 236,701 | |||
Intangible assets, net (including goodwill) | 1,000,241 | 785,651 | 620,241 | 385,413 | 428,492 | 458,156 | |||
Intangible assets, net (excluding goodwill) | 1,000,241 | 785,651 | 620,241 | 385,413 | 428,492 | 458,156 | |||
Other noncurrent assets | 11,774 | 227,192 | 227,192 | 537,812 | 835,107 | 1,444,798 | |||
Other undisclosed noncurrent assets | 4,809,376 | ||||||||
Total noncurrent assets: | 1,167,662 | 1,261,548 | 1,229,690 | 1,235,123 | 1,425,771 | 6,949,031 | |||
TOTAL ASSETS: | 4,371,606 | 6,644,833 | 7,758,018 | 4,150,906 | 7,021,527 | 20,781,436 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 2,912,195 | 2,656,901 | 1,948,845 | 2,050,696 | 2,074,831 | 1,789,776 | |||
Employee-related liabilities | ✕ | ✕ | 1,194,719 | 755,494 | 925,009 | 1,637,337 | 915,672 | ||
Accounts payable | 2,122,538 | 1,421,317 | 1,161,717 | 1,112,069 | 424,718 | 855,043 | |||
Accrued liabilities | 789,657 | 40,865 | 31,634 | 13,618 | 12,776 | 19,061 | |||
Deferred revenue | 800,000 | ✕ | ✕ | ||||||
Debt | 543,613 | 453,427 | 745,443 | 556,508 | 316,074 | 2,353,639 | |||
Estimated litigation liability | 2,887,566 | ||||||||
Disposal group, including discontinued operation | 7,092 | ||||||||
Other undisclosed current liabilities | 5,686,081 | 2,189,474 | 2,020,817 | 1,212,347 | 987,613 | 1,030,330 | |||
Total current liabilities: | 9,941,889 | 5,299,802 | 4,715,105 | 3,819,551 | 3,378,518 | 8,068,403 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation: | 20,288 | 296,006 | 512,344 | ||||||
Liabilities, other than long-term debt | 2,573,027 | 700,000 | 700,000 | 700,000 | 64,055 | 76,611 | |||
Deferred revenue | 700,000 | 700,000 | 700,000 | 700,000 | ✕ | ✕ | |||
Due to related parties | ✕ | 1,871,715 | |||||||
Other liabilities | 64,055 | 76,611 | |||||||
Operating lease, liability | 1,312 | 20,288 | 296,006 | 512,344 | ✕ | ✕ | |||
Other undisclosed noncurrent liabilities | 1,168,494 | 588,092 | |||||||
Total noncurrent liabilities: | 2,573,027 | 720,288 | 996,006 | 1,212,344 | 1,232,549 | 664,703 | |||
Total liabilities: | 12,514,916 | 6,020,090 | 5,711,111 | 5,031,895 | 4,611,067 | 8,733,106 | |||
Equity | |||||||||
Equity, attributable to parent, including: | (8,435,828) | (106,556) | 1,315,604 | (1,612,292) | 1,742,139 | 11,379,630 | |||
Preferred stock, shares subscribed but unissued, subscriptions receivable | (10,300,000) | ||||||||
Common stock | 223,684 | 221,277 | 218,146 | 210,232 | 200,391 | 162,207 | |||
Common stock, share subscribed but unissued, subscriptions receivable | (4,975,000) | ||||||||
Common stock, value, subscriptions | 995 | 902 | |||||||
Additional paid in capital | 379,343,124 | 370,459,705 | 375,428,014 | 345,847,676 | 338,265,383 | 331,128,787 | |||
Accumulated other comprehensive loss | (730) | (2,396) | |||||||
Accumulated deficit | (388,002,649) | (370,787,610) | (359,056,683) | (347,671,102) | (336,722,905) | (319,908,968) | |||
Other undisclosed equity, attributable to parent | 13 | 72 | 132 | ||||||
Equity, attributable to noncontrolling interest | 292,518 | 731,299 | 731,303 | 731,303 | 668,321 | 668,700 | |||
Total equity: | (8,143,310) | 624,743 | 2,046,907 | (880,989) | 2,410,460 | 12,048,330 | |||
TOTAL LIABILITIES AND EQUITY: | 4,371,606 | 6,644,833 | 7,758,018 | 4,150,906 | 7,021,527 | 20,781,436 |
Income Statement (P&L) (USD)
9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 65,652 | 531,513 | 915,013 | 657,826 | 1,169,351 | 1,810,437 | ||
Sublease income | 378,000 | ✕ | ✕ | |||||
Cost of revenue | (1,941) | (1,048) | (6,667) | (96,636) | (3,651) | |||
Cost of goods and services sold | (183,006) | (3,651) | ||||||
Other undisclosed gross profit | (183,006) | |||||||
Gross profit: | (119,295) | 531,513 | 913,965 | 651,159 | 1,072,715 | 1,806,786 | ||
Operating expenses | (13,931,600) | (12,591,925) | (11,625,146) | (11,613,676) | (11,920,016) | (15,683,793) | ||
Operating loss: | (14,050,895) | (12,060,412) | (10,711,181) | (10,962,517) | (10,847,301) | (13,877,007) | ||
Nonoperating income (expense) | (1,126,261) | (20,476) | (10,510) | 17,675 | 1,145 | (33,339) | ||
Investment income, nonoperating | (1,098,322) | (6,361) | 11,344 | 25,288 | ||||
Other nonoperating income (expense) | (27,939) | (14,115) | (21,854) | (7,613) | 1,145 | (33,339) | ||
Interest and debt expense | (344,024) | 366,000 | (6,000) | (8,000) | (5,291,616) | (4,201,668) | ||
Loss from continuing operations before equity method investments, income taxes: | (15,521,180) | (11,714,888) | (10,727,691) | (10,952,842) | (16,137,772) | (18,112,014) | ||
Other undisclosed income (loss) from continuing operations before income taxes | 344,024 | 6,000 | 8,000 | (30,799) | 322,328 | |||
Loss from continuing operations before income taxes: | (15,177,156) | (11,714,888) | (10,721,691) | (10,944,842) | (16,168,571) | (17,789,686) | ||
Income tax expense (benefit) | (16,043) | (707) | 9,753 | 4,062,489 | ||||
Loss from continuing operations: | (15,177,156) | (11,730,931) | (10,721,691) | (10,945,549) | (16,158,818) | (13,727,197) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | (11,730,931) | (10,721,691) | (10,948,214) | (16,158,818) | (13,727,197) | |
Loss from discontinued operations | (2,665) | |||||||
Other undisclosed net income | 44,502 | 88,673,053 | ||||||
Net income (loss): | (15,177,156) | (11,730,931) | (10,721,691) | (10,948,214) | (16,114,316) | 74,945,856 | ||
Net income attributable to noncontrolling interest | 3 | 4 | 17 | 379 | 210 | |||
Net income (loss) attributable to parent: | (15,177,153) | (11,730,927) | (10,721,691) | (10,948,197) | (16,113,937) | 74,946,066 | ||
Preferred stock dividends and other adjustments | (2,037,886) | (663,889) | ||||||
Other undisclosed net loss available to common stockholders, basic | ||||||||
Net income (loss) available to common stockholders, diluted: | (17,215,039) | (11,730,927) | (11,385,580) | (10,948,197) | (16,113,937) | 74,946,066 |
Comprehensive Income (USD)
9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (15,177,156) | (11,730,931) | (10,721,691) | (10,948,214) | (16,114,316) | 74,945,856 | ||
Other undisclosed comprehensive income (loss) | 730 | 1,666 | (2,396) | |||||
Comprehensive income (loss): | (15,177,156) | (11,730,931) | (10,721,691) | (10,947,484) | (16,112,650) | 74,943,460 | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | 3 | 4 | 17 | 379 | 210 | |||
Comprehensive income (loss), net of tax, attributable to parent: | (15,177,153) | (11,730,927) | (10,721,691) | (10,947,467) | (16,112,271) | 74,943,670 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.